CN1301762C - Apparatus for treating Aids - Google Patents
Apparatus for treating Aids Download PDFInfo
- Publication number
- CN1301762C CN1301762C CNB021138044A CN02113804A CN1301762C CN 1301762 C CN1301762 C CN 1301762C CN B021138044 A CNB021138044 A CN B021138044A CN 02113804 A CN02113804 A CN 02113804A CN 1301762 C CN1301762 C CN 1301762C
- Authority
- CN
- China
- Prior art keywords
- magnetic
- sound source
- control
- aids
- heavy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
The present invention relates to a medical instrument for treating AIDS designed by a physical immunity (field immunity) conception which is a magnetic-weight sound field. The present invention is composed of a tunnel-type main body, a magnetic-weight sound source, a movable treating bed and a control platform. The present invention overcomes the defects of the existing medicine for treating AIDS and provides an AIDS treating machine having the advantages of simple structure and low cost; the present invention also has the advantages that functions of human immune systems are effectively improved, immune cells damaged by AIDS viruses are activated, integrative immune functions of patients are reconstructed, the responding capacity to AIDS virus infection probability and AIDS virus specific immunity is improved, and the AIDS viruses are effectively inhibited and killed without any obvious adverse reaction.
Description
Technical field the present invention relates to Medical Instruments.Particularly utilize the Medical Instruments of the heavy sound field treatment of magnetic acquired immune deficiency syndrome (AIDS).
Technical background is over 20 years, and the people of global aids infection virus (HIV) surpasses 5,800 ten thousand, to dead 2,200 ten thousand people of calendar year 2001 accumulative total.HIV sufferers 250,000 examples found of China estimate that according to the expert actual number of the infected surpasses 600,000, and to be higher than 30% speed increment every year.
Acquired immune deficiency syndrome (AIDS) does not have effective treatment means so far.The HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) speed of mutation is too fast, and the Drug resistance of generation makes vaccine and the drug failure that prevents AIDS.Though multiple treatment AIDS-treating medicine is used (HAART) together, can reduce the acquired immune deficiency syndrome (AIDS) mortality rate, prolong patient's life, expense is surprising, is difficult to promote in developing country.Be exactly above-mentioned therapy, also can't thoroughly kill HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) that is in resting state just can be brought back to life as occasion serves, quickens to duplicate diffusion.At " external techwatch " the 9th phase of calendar year 2001 3-12 page or leaf acquired immune deficiency syndrome (AIDS) special topic: " medicine of existing AIDS virus resisting can stop duplicating of virus to a certain extent; but can not treatment of AIDS viral infection person and acquired immune deficiency syndrome (AIDS), and have than serious adverse.Some nucleoside reverse transcriptase inhibitor can cause cell and leukocyte disappearance, and is all the more so when particularly acquired immune deficiency syndrome (AIDS) is taken late period.Other nucleoside reverse transcription acid inhibitors can cause pancreas inflammation and nervous system to destroy.Also have various complication and other serious drug reaction even cause death.Protease suppresses side effect and comprises nauseating, diarrhoea and other gastrointestinal symptoms, can also react with other medicines, has side effects." " so far, HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) can be killed all without any a kind of AIDS virus resisting medicine, if want to eradicate HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), must raise immunity.The comprehensive immunologic function of rebuilding the patient reaches replys at the specific immune of waiting for an opportunity to infect with HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), can kill the residual virus of hiding." " HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) is attacked human body CD4
+ TCell, how activating the immunocyte that has been damaged also is a very arduous challenge.”
Summary of the invention the object of the present invention is to provide and the method for Applied Physics immunity (immunity) overcome the weak point of chemo-immunity in the prior art (medicine immunity) treatment acquired immune deficiency syndrome (AIDS) and provide a kind of relatively simple for structure, cost is lower, can effectively improve human immune system's function, activation is subjected to the immunocyte of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) damage, rebuild patient's comprehensive immunologic function, raising waits for an opportunity to infect specific immune responsibility with HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) to HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), can effectively suppress to kill and wound the apparatus for treating Aids of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), no obvious adverse reaction.For human treatment's acquired immune deficiency syndrome (AIDS) provides a kind of new design and equipment.
Theoretical foundation of the present invention is: the interior environment of forming the most basic small tissue (cell, nucleus, cell membrane, Cell sap, albumen, enzyme, nucleic acid, gene, the base equity) existence of life entity can be considered field, organic little territory, gene are field, organic little territory chain, and the field of external environment condition is the field, foreign lands.Under certain field, foreign lands and the organic little territory field interactions, reach the biobalance attitude between the two, cell then can normally be survived, and gene then can normally duplicate, and albumen, enzyme are normally synthetic and bring into play its function.If be in nonequilibrium state, will be suppressed even death.The field, organic little territory in the responsive site of gene is subjected to regulation and control excitation, the enhancing of field, foreign lands, and gene replication speed may be accelerated, and the vigor of cell, albumen, enzyme increases, and then can be suppressed on the contrary even can't duplicate, and bioprotein, enzyme are subjected to the regulation and control of field, foreign lands.To the natural magnetic field of the overall process of life, gravity (gravitation) harmony (vibration) is unusual key factor.Utilize HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) and normal cell to apply the heavy sound field of low frequency magnetic selectively, impel the strand of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) gene and double-strand break to rise, quicken the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) degeneration necrosis what the difference of permeability, conductivity, dielectric constant caused.Simultaneously, utilize the heavy sound of magnetic to wait physical field to improve the replication rate of immunocyte gene, promote gene synthetic, enhance immunity specific reaction and replying improves function of immune system as a result, and this method is called physics immunity (immune).According to this theory, therefore, can effectively improve function of immune system, activate the immunocyte that is subjected to the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) damage, the comprehensive immunologic function of rebuilding the patient by the heavy sound field of the synthetic magnetic of special control law, raising strengthens the ability that AIDS virus resisting waits for an opportunity to infect to the specific immune responsibility of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus).Simultaneously, suppress reverse transcriptase effectively.Because the heavy sound wave of magnetic adopts frequency agility and pre-programmed signal modulation (now ripe) technology, the heavy sound wave energy of magnetic is selected among multiple signal pattern, multiple frequency, multiple assembled state on demand, fast and effeciently to suppress to kill and wound, quicken its degeneration necrosis far above the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) speed of mutation.
The present invention is made up of the heavy sound source of main body, magnetic of tunnel type, mobile therapeutic bed, control station.(1) is provided with installing rack in the upper and lower, left and right of tunnel type main body, each installing rack can be arranged the heavy sound source of 1-8 platform magnetic, on the installing rack of tunnel type main body, also be provided with 2-38 magnetic excitation coil and 2-38 binding post, magnetic excitation coil is provided with magnetic shield outward, installing rack is provided with 2-26 acoustic generator, and the centre of tunnel type main body is the tunnel type treatment space that is surrounded by the dielectric-slab that has scanning holes; (2) the heavy sound source of the magnetic on the installing rack is installed in shielding-harmonic shock cover by annular damping noise reduction pad, the bottom of shielding-harmonic shock cover and have the noise abatement hole louvre of holding concurrently all around; Be with a rolling disc in the rotating shaft of the heavy sound source of magnetic by buncher, shrinkage pool is arranged on the rolling disc, be embedded with kicker magnet in the shrinkage pool, all be embedded with magnetic shield between rolling disc and the kicker magnet, have pressing plate or pressure ring to compress kicker magnet; On rolling disc, also be provided with magnetic excitation coil and binding post; The top of motor is provided with fixing head, and its surface is parallel with rolling disc, has the hole on the fixing head, is connected and fixed the sound source head; (3) removable therapeutic bed makes bed surface advance in tunnel type treatment space or retreat along guide rail by a pendulum position system, is made up of slide rail, driving device and localizer; (4) control station is controlled magnetic field impulse frequency, burst of pulses and the integrated intensity of the heavy sound source of magnetic with electronic circuit or computer, to monitoring, form simultaneously by control template, control panel, special switch and computer, interface board, special-purpose software by the duty of pendulum position system; (5) the computer control circuit is the power supply of computer, variable-frequency governor by regulated power supply, and computer provides control signal to variable-frequency governor and makes the heavy sound source work of magnetic, and available common, fuzzy or chaos controlling program realizes common, fuzzy or chaos controlling.
The present invention compared with prior art has following advantage:
1. the present invention can increase immune function of human body effectively through evidence, activates the immunocyte of damaged, improves the specific immune responsibility, strengthens anti-ability of waiting for an opportunity to infect.The present invention shows through zoopery and long-term clinical observation: the interleukin-2-receptor (IL-2R, IL-12R) of interleukin (IL-2, IL-12) is increased; Make CD4
+T, CD8
+T and CD3
+T increases; Folliculus shape dendritic cell (FDCs) are increased; Interferon-' alpha ', interferon-are increased, help rebuilding patient's comprehensive immunologic function.
Rat soluble interleukin-6-2 receptor result of variations
| Group | Different time (my god) and interleukin-2 R (IU/ml) | ||||
| 7 | 14 | 30 | 60 | 90 | |
| The test group matched group | 143.00±20.00 * 126.00±14.00 | 156.00±14.00 * 129.00±0.00 | 169.00±33.00 △ 135.00±12.00 | 150.00±32.00 * 136.00±0.00 | 201.00±41.00 △ 132.00±8.00 |
*P＜0.05 △P＜0.01
Rat treatment different time CH
50Measurement result
| Group | The treatment different time (my god) and and CH 50(IU/ml) | ||||
| 7 | 14 | 30 | 60 | 90 | |
| The test group matched group | 91.50±46.60 * 83.30±16.70 | 81.50±52.00 78±38.20 | 133.00±0.00 133.00±0.00 | 149.75±29.00 △ 99.80±33.20 | 166.50±33.50 * 155.30±43.30 |
*P＜0.05 △P＜0.01
Rat treatment different time determination of immunoglobulin result
| Project | Group | Different time (my god) and immunoglobulin (IU/ml) | ||||
| 7 | 14 | 30 | 60 | 90 | ||
| IgG | The test group matched group | 96.20±10.40 * 87.80±21.00 | 129.90±35.70 * 98.80±20.20 | 129.40±40.60 133.30±67.10 | 119.10±20.00 △ 95.60±10.90 | 129.90±38.80 116.40±32.60 |
| IgA | The test group matched group | 170.70±36.40 △ 126.50±32.20 | 257.80±10.50 △ 207.90±35.20 | 239.30±47.10 △ 197.30±37.80 | 174.10±26.20 △ 160.20±15.20 | 127.60±15.20 * 106.00±21.60 |
*P＜0.05 △P＜0.01
2. gastro-intestinal digestion system, hemopoietic system and nervous system there are the coordinated regulation therapeutical effect, and tangible curative effect is arranged;
3. the present invention has inhibitory action with enough high strength and long treatment to reverse transcriptase and virus protein, enzyme, makes the RNA reverse transcription of HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) be difficult to carry out, thereby quickens the HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) degeneration necrosis.Useful albumen, enzyme there are activation potentiation, bring into play the peculiar two-way choice adjusting function of the heavy ping of many gradients magnetic;
4. after the doses treatment, patient's appetite increases, full of vitality, body weight gain, and life quality obviously improves;
Mice body weight change result
| Group | Treatment time (my god) and body weight (g) | ||
| 0 | 10 | 20 | |
| The test group matched group | 21.91±1.08 22.18±0.61 | 28.66±1.66 27.05±1.52 | 33.04±0.54 * 28.88±2.91 |
*P＜0.05
5. this therapy apparatus is safe and reliable, does not find the side effect that shows.Through long-term clinical observation proof hemogram index, biochemical indicator, hormonal system, nervous system, audition, vision and the heart, liver,spleen,kidney, lung, gastrointestinal, pancreas, urinary system etc. are had no adverse effects, and the function of improvement is arranged;
Mouse test group routine blood test index
| Project | Treatment time (my god) and the routine | |
| 10 | 20 | |
| WBC(×10 9Individual/L) N (%) L (%) PLT (* 10 9/L) Hb(g/L) | 11.26±1.75 23.49±9.66 76.24±7.41 200.3±23.10 △ 139.88±0.83 | 11.35±6.16 32.41±3.08 67.45±2.91 221.3±7.79 △ 142.37±7.92 * |
△P＜0.01 *P＜0.05
Mice matched group routine blood test change indicator
| Project | Treatment time (my god) and the routine | |
| 10 | 20 | |
| WBC(×10 9Individual/L) N (%) L (%) PLT (* 10 9/L) Hb(g/L) | 10.72±9.18 20.34±12.22 76.88±12.00 172.30±25.40 127.53±24.78 | 10.99±16.42 30.05±9.22 67.95±7.78 190.30±29.60 132.99±0.33 |
△P＜0.01 *P＜0.05
The result of variations of mouse test organ coefficient
| Group | Cardiopulmonary | Spleen | Liver | Kidney | Body weight |
| Test group organ coefficient (%) matched group organ coefficient (%) | 0.5±0.06 1.15 0.47±0.08 1.57 | 0.22±0.08 * 0.66 0.16±0.07 0.54 | 2.64±0.97 * 1.99 1.75±0.36 5.85 | 0.54±0.09 1.63 0.51±0.11 1.71 | 33.04±0.54 29.88±2.91 |
*P＜0.05
Rat test group routine blood test result of variations
| Project | Treatment time and routine blood test index | ||||
| 7 | 14 | 30 | 60 | 90 | |
| WBC(×10 9Individual/L) N (%) L (%) M (%) A (%) Hb (g/L) | 22.00±2.75 9.30±6.70 90.75±2.60 0 0 126.70±7.60 | 21.65±1.1.27 9.25±2.60 90.75±3.40 0 0 129.00±12.10 | 19.35±2.35 9.25±3.70 90.75±3.14 0 0 136.50±11.40 * | 19.35±3.98 11.75±13.80 86.00±16.20 2.00±2.80 0 132.50±8.10 △ | 18.43±2.09 12.30±5.10 87.70±5.10 0 0 139.60±14.70 △ |
*P＜0.05 △P＜0.01
Rat test matched group routine blood test result of variations
| Project | Treatment time and routine blood test index | ||||
| 7 | 14 | 30 | 60 | 90 | |
| WBC(×10 9Individual/L) N (%) L (%) M (%) A (%) Hb (g/L) | 19.70±1.56 9.50±1.40 90.50±0.70 0 0.50±0.70 128.00±3.00 | 17.60±5.70 9.25±4.90 90.50±4.90 0 0 126.00±5.70 | 17.3±5.20 10.00±1.40 90.75±1.40 0 0 126.00±0.00 | 18.70±9.90 10.50±0.70 89.50±0.70 0 0 118.00±0.00 | 16.76±2.53 10.00±2.70 90.00±2.70 0 0 114.70±7.20 |
Rat test group blood results of biochemical
| Project | Treatment time (my god) and biochemical indicator | ||||
| 7 | 14 | 30 | 60 | 90 | |
| TP(g/L) ALB(g/L) GLU(mmol/L) CHDL(mmmol/L) ALP(IU/ml) | 78.20±5.10 44.40±2.50 7.04±1.00 2.13±0.15 468.3±137.00 | 89.60±11.30 44.60±4.90 5.07±1.54 2.81±0.33 495.00±148.00 | 86.00±12.10 45.30±10.40 5.17±1.54 2.13±1.20 514.00±119.00 | 78.80±3.30 40.40±1.70 5.72±0.23 2.31±0.05 470.00±121.00 | 88.50±11.80 42.20±4.30 5.38±1.42 2.13±0.26 488.00±182.00 |
Rat matched group blood results of biochemical
| Project | Treatment time (my god) and biochemical indicator | ||||
| 7 | 14 | 30 | 60 | 90 | |
| TP(g/L) ALB(g/L) GLU(mmol/L) CHDL(mmmol/L) ALP(IU/m1) | 78.20±2.90 43.90±3.70 7.70±0.10 2.80±0.11 453.00±190.00 | 75.60±10.10 48.50±3.80 5.60±0.28 2.20±0.68 389.00±127.00 | 84.60±0.30 44.30±3.30 5.55±0.71 2.13±0.30 422.00±7.80 | 75.70±8.30 46.30±5.70 5.23±0.78 2.32±0.70 470.00±247.00 | 84.70±3.90 42.40±3.34 5.60±0.84 1.96±0.52 432.00±89.00 |
6. the present invention has the effect that promotes variation to lymph surface chemotactic factor CCR2 and CCR5, to postponing the acquired immune deficiency syndrome (AIDS) morbidity and being difficult for aids infection virus, produces antibody of AIDS virus to promoting human body, and is very favourable.
Rat periphery blood lymphocyte conversioning test result
| Project | Treatment time (my god) and cell transformation rate (%) | ||||
| 7 | 14 | 30 | 60 | 90 | |
| The test group matched group | 0.53±0.00 * 0.40±0.00 | 0.60±0.02 * 0.43±0.07 | 0.53±0.09 * 0.41±0.07 | 0.56±0.06 0.49±0.04 | 0.59±0.00 * 0.41±0.03 |
*P＜0.05
7. this therapy apparatus advanced design, harmless to patient and medical personnel and Environmental security, and cost is low, maintainable good, reliability height, life-span are long, easy to use.
Be the drawing explanation of Figure of description of the present invention below the description of drawings:
Fig. 1 is that system of the present invention constitutes schematic front view.
Fig. 2 is that system of the present invention constitutes the signal left view.
Fig. 3 is the cutaway view of the heavy sound source of the common or superconducting coil magnetic of the present invention.
Fig. 4 is the vertical view of the heavy sound source of the common or superconducting coil magnetic of the present invention.
Fig. 5 is the cutaway view of the heavy sound source of magnetic of the present invention.
Fig. 6 is the vertical view of the heavy sound source of magnetic of the present invention.
Fig. 7 is the theory diagram of the electronic control circuit of the heavy sound source of magnetic of the present invention.
Fig. 8 is the program control type line principle block diagram that prelists of the heavy sound source of magnetic of the present invention.
Fig. 9 is the electronic computer control sequence schematic diagram of the heavy sound source of magnetic of the present invention.
The present invention is described in further detail below with reference to embodiment and accompanying drawing:
Specific embodiment embodiment 1 is referring to Figure of description 1-9, a kind of apparatus for treating Aids is by the main body 1 of tunnel type (tunnel type treatment space is a rectangle in the present embodiment), the heavy sound source 2 of magnetic, therapeutic bed 3, control station 4 is formed: (1) is on the tunnel type main body, down, a left side, the right side is provided with installing rack 5, each installing rack is arranged the heavy sound source 2 of 1-8 platform magnetic, on the installing rack of tunnel type main body, also be provided with 2-38 magnetic excitation coil 6 and 2-38 binding post 7, this magnetic excitation coil is common or superconduction 8 fonts, coil and sense of current can be left-handed can be dextrorotation also, coil axis is adjustable.Magnetic excitation coil is provided with magnetic shield 8 outward, and installing rack is provided with 2-26 acoustic generator 9, and the centre of tunnel type main body is the tunnel type treatment space that is surrounded by the dielectric-slab 11 that has scanning holes 10.(2) the heavy sound source 2 of the magnetic on the installing rack is installed in shielding-harmonic shock cover 13 by annular damping noise reduction pad 12.The annular cushion is to be composited by special purpose spring corrugated steel and high elastic rubber, sponge.The bottom of shielding-harmonic shock cover and have the noise abatement hole louvre 14 of holding concurrently all around, the noise abatement hole decays to 5-20dB with unwanted audio frequency; The heavy sound source structure of magnetic is as follows: be with a rolling disc 16 in the rotating shaft of buncher 15, rolling disc is made by reinforced plastics, carbon fibre composite or metal material.3-180 shrinkage pool 17 arranged on the rolling disc, be linearity or nonlinear Distribution, symmetry or asymmetric geometry.Be embedded with kicker magnet 18 in the shrinkage pool, be rare-earth permanent magnet or ferrum oxygen permanent magnet, magnetic induction is 0.1mT-12T/S.All be embedded with magnetic shield 19 between rolling disc and the kicker magnet, have pressing plate or pressure ring 20 to compress kicker magnet; The top of motor is provided with fixing head 21, and plate face edge is than thick middle, and its surface is parallel with rolling disc, and keeps at a distance, and has 2-160 hole 22 on the fixing head, is connected and fixed sound source 23 below the fixing head.(3) removable therapeutic bed makes bed surface advance in tunnel type treatment space or retreat along slide rail 24 by a pendulum position system, and a pendulum position system is made up of slide rail, driving device 26 and localizer 27.That adopt in this tunnel type treatment space is cylindrical, rectangle or polygon (as Fig. 1 is rectangle, and Fig. 5 is a polygon).(4) control station 4 usefulness electronic circuits and computer are controlled magnetic field impulse frequency, burst of pulses and the integrated intensity of the heavy sound source of magnetic, also the duty of pendulum position system is monitored simultaneously, formed by control template, control panel, special switch and computer, interface board, special-purpose software; The control table top has display 28, PC main frame 29, operation keyboard 30, character display 31, Artificial Control panel 32, host computer control cable 33 and therapeutic bed control cable 34; (5) the computer control circuit is computer, buncher power supply by regulated power supply, and computer provides control signal and makes the heavy sound source work of magnetic, realizes common, fuzzy or chaos controlling with common, fuzzy or chaos controlling program.
The rotating speed of the heavy sound source buncher of designed magnetic is 0-10000 rev/min, and the frequency of magnetic field impulse is that the heavy ping number of 0-8MHz, magnetic is 0-6.8 * 10
9Individual/second, sound frequency rate is 0-48MHz, and sound field comprises infrasonic sound, low, middle and high frequency rate, ultrasonic, its equivalent sound level≤70dB (A), and acoustical power is 1-100mW/cm
2
The concrete control of computer of the present invention is as follows: initialize routine is carried out in the start back, on display, show the start original state subsequently, wait for the heavy sound source operating frequency setting of keyboard input magnetic, select two dimension or three-dimensional control sequence with keyboard or mouse then, select control cycle again, 10 minutes or 15 minutes, the process procedures name has been made the control key of icon and band literal at desktop system, use the click control key, process control is carried out automatically, until end.
The designed apparatus for treating Aids of the present invention can be applied to treat acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient.The method of using is: the patient that will suffer from the patient of acquired immune deficiency syndrome (AIDS) or carry HIV (human immunodeficiency virus) (Human Immunodeficiency Virus) sends on the removable therapeutic bed, gauge tap on the start-up control platform, patient is sent into tunnel type treatment space, start the heavy sound source of magnetic, patient is in the heavy sound field of magnetic, patient was treated 10-30 minute, and every day 1-2 time, look patient's state of an illness and order each course of treatment.
The designed apparatus for treating Aids of the present invention can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
The designed apparatus for treating Aids of the present invention can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
The designed apparatus for treating Aids of the present invention can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
The designed apparatus for treating Aids of the present invention can be applied to treat method that acquired immune deficiency syndrome (AIDS), AIDS virus carrier and other immunologic hypofunction or hyperfunction patient use with embodiment 1.
Claims (9)
1. apparatus for treating Aids: it is characterized in that: the heavy sound source (2) of main body (1), magnetic, therapeutic bed (3), control station (4) by tunnel type are formed:
1.1 be provided with installing rack (5) in the upper and lower, left and right of tunnel type main body, each installing rack is arranged the heavy sound source (2) of 1-8 platform magnetic, on the installing rack of tunnel type main body, also be provided with 2-38 magnetic excitation coil (6) and 2-38 binding post (7), magnetic excitation coil is provided with magnetic shield (8) outward, installing rack is provided with 2-26 acoustic generator (9), and the centre of tunnel type main body is the tunnel type treatment space that is surrounded by the dielectric-slab that has scanning holes (10) (11);
1.2 the heavy sound source of the magnetic on the installing rack (2) is installed in shielding-harmonic shock cover (13) by annular damping noise reduction pad (12), the bottom of shielding-harmonic shock cover and have the noise abatement hole louvre (14) of holding concurrently all around; The structure of the heavy sound source of magnetic is as follows: be with a rolling disc (16) in the rotating shaft of buncher (15), 3-180 shrinkage pool (17) arranged on the rolling disc, be embedded with kicker magnet (18) in the shrinkage pool, all be embedded with magnetic shield (19) between rolling disc and the kicker magnet, have pressing plate or pressure ring (20) to compress kicker magnet; The top of motor is provided with fixing head (21), and plate face edge is than thick middle, and its surface is parallel with rolling disc, and keeps at a distance, and has 2-160 hole (22) on the fixing head, and the fixing head below is connected and fixed sound source (23);
1.3 removable therapeutic bed makes bed surface advance in tunnel type treatment space or retreat along slide rail (24) by a pendulum position system, a pendulum position system is made up of slide rail, driving device (26) and localizer (27);
1.4 control station (4) is controlled the heavy ping number of magnetic field impulse frequency, magnetic, sound frequency rate, sound field, acoustical power and the integrated intensity of the heavy sound source of magnetic with electronic circuit and computer, also the duty of pendulum position system is monitored simultaneously, hardware components is made up of control template, control panel, special switch and computer, interface board, special-purpose software; The control table top has display (28), PC main frame (29), operation keyboard (30), character display (31), Artificial Control panel (32), host computer control cable (33) and therapeutic bed control cable (34);
1.5 the computer control circuit is computer, buncher power supply by regulated power supply, computer provides control signal and makes the heavy sound source work of magnetic, realizes common, fuzzy or chaos controlling with common, fuzzy or chaos controlling program;
1.6 wherein concrete control is as follows: initialize routine is carried out in the start back, on display, show the start original state subsequently, wait for the heavy sound source operating frequency setting of keyboard input magnetic, select two dimension or three-dimensional control sequence with keyboard or mouse then, select control cycle again, 10 minutes or 15 minutes, the process procedures name has been made the control key of icon and band literal at desktop system, use the click control key, process control is carried out automatically, until end.
2. apparatus for treating Aids according to claim 1 is characterized in that: said rolling disc is made by reinforced plastics, carbon fibre composite or metal material in 1.2.
3. apparatus for treating Aids according to claim 1 is characterized in that: the shrinkage pool of the 3-180 in 1.2 on the said rolling disc is linearity or nonlinear Distribution, symmetry or asymmetric geometry.
4. apparatus for treating Aids according to claim 1 is characterized in that: the kicker magnet that said rolling disc embeds in 1.2 is rare-earth permanent magnet or ferrum oxygen permanent magnet, and magnetic induction is 0.1mT-12T/S.
5. apparatus for treating Aids according to claim 1 is characterized in that: the rotating speed of the heavy sound source buncher of magnetic is 6-10000 rev/min, and the frequency of magnetic field impulse is that the heavy ping number of 0-8MHz, magnetic is 0-6.8 * 10
9Individual/second, sound frequency rate is 0-48MHz, and sound field comprises infrasonic sound, low, middle and high frequency rate, ultrasonic, its equivalent sound level≤70dBA, and acoustical power is 1-100mW/cm
2
6. apparatus for treating Aids according to claim 1 is characterized in that: the magnetic excitation coil in 1.1 on the said tunnel type main body is common or superconduction 8 fonts, coil and sense of current can be left-handed can be dextrorotation also, coil axis is adjustable.
7. apparatus for treating Aids according to claim 1 is characterized in that: the noise abatement hole of said shielding-harmonic shock cover decays to 5-20dB with unwanted audio frequency in 1.2.
8. apparatus for treating Aids according to claim 1, its feature in: said annular damping noise reduction pad is to be composited by special purpose spring corrugated steel and high elastic rubber, sponge in 1.2.
9. apparatus for treating Aids according to claim 1 is characterized in that: cylindrical, rectangle or polygon are adopted in said tunnel type treatment space in 1.3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021138044A CN1301762C (en) | 2002-05-31 | 2002-05-31 | Apparatus for treating Aids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021138044A CN1301762C (en) | 2002-05-31 | 2002-05-31 | Apparatus for treating Aids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1461660A CN1461660A (en) | 2003-12-17 |
| CN1301762C true CN1301762C (en) | 2007-02-28 |
Family
ID=29742231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021138044A Expired - Fee Related CN1301762C (en) | 2002-05-31 | 2002-05-31 | Apparatus for treating Aids |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1301762C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103100141A (en) * | 2013-02-18 | 2013-05-15 | 桂林医学院 | Acquired immune deficiency syndrome (AIDS) immune function recovering device |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077655A (en) * | 1992-11-21 | 1993-10-27 | 邹剑钢 | Medical biologic NMR technique |
| WO1999019936A1 (en) * | 1997-10-14 | 1999-04-22 | Hex Technology Holdings Limited | Electric and magnetic field generator, corresponding field detector, and sample analyser |
| JP2000212196A (en) * | 1999-01-21 | 2000-08-02 | Ee H C:Kk | Physiologically active substance dm9809 and medicine containing the same as active ingredient |
| CN2553828Y (en) * | 2002-05-31 | 2003-06-04 | 王德全 | AIDS treatment apparatus |
-
2002
- 2002-05-31 CN CNB021138044A patent/CN1301762C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1077655A (en) * | 1992-11-21 | 1993-10-27 | 邹剑钢 | Medical biologic NMR technique |
| WO1999019936A1 (en) * | 1997-10-14 | 1999-04-22 | Hex Technology Holdings Limited | Electric and magnetic field generator, corresponding field detector, and sample analyser |
| JP2000212196A (en) * | 1999-01-21 | 2000-08-02 | Ee H C:Kk | Physiologically active substance dm9809 and medicine containing the same as active ingredient |
| CN2553828Y (en) * | 2002-05-31 | 2003-06-04 | 王德全 | AIDS treatment apparatus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1461660A (en) | 2003-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1032676C (en) | Low frequency rotation permanent magnetic field therapeutic device | |
| WO1995004572A1 (en) | A method of the magnetic therapy and a magnetic device of magnetic field scanning | |
| CN1032420A (en) | Utilize magnetic force treatment human body not accommodate the device of disease | |
| CN1301762C (en) | Apparatus for treating Aids | |
| CN2553828Y (en) | AIDS treatment apparatus | |
| CN102755512A (en) | Traditional Chinese medicine extract capable of improving CIK cell proliferation rate as well as preparation method and application of same | |
| Goldshmit et al. | Treatment with pulsed extremely low frequency electromagnetic field (PELF-EMF) exhibit anti-inflammatory and neuroprotective effect in compression spinal cord injury model | |
| Marx | Cancer Vaccines Show Promise at Last: In early clinical trials, tumor cell vaccines appear able to help cancer patients fight off metastases by stimulating immune responses to the patients' tumors | |
| CN105254744A (en) | Heterologous expression of polypeptide XZZ-5 and application of polypeptide XZZ-5 to enhancement of tumor killing activity of CIK (Cytokine Induced Killer) cells | |
| CN1861191A (en) | Application of human sDR5 protein as medicine to treat virus hepatitis B | |
| CN105132372B (en) | A kind of application of the compound in tumour cell immunization therapy inducing DC-CIK cell | |
| CN104829708B (en) | The leptin activity peptide of one D spiral region mutation and its encoding gene and application | |
| CN110898333A (en) | Health management instrument for assisting in repairing anxiety and depression and use method | |
| Sun et al. | T cells and liver fibrosis | |
| Palmieri et al. | Propionibacterium acnes: a putative immunemodulating weapon against the coronavirus impending epidemy | |
| CN1282491C (en) | Therapeutic device for curing diabetes and cardiovascular disease | |
| CN103710308A (en) | Method for inducing DC-CIK by utilizing muramyl dipeptide | |
| CN104829705B (en) | The leptin activity peptide of one C spiral region mutation and its encoding gene and application | |
| US20220152195A1 (en) | Methods of preventing and treating viral infections | |
| Mickel et al. | Granuloma annulare and radial pulse therapy: preliminary findings | |
| Naylor et al. | Preclinical studies with IRX‐2 and thymosin α1 in combination therapy | |
| UA87110U (en) | Method for treating chronic viral hepatitis c | |
| Chen et al. | Effects of Ganoderma lucidum on cellular immunocompetence in γ‐irradiated mice | |
| Akagun et al. | MO830: Evaluation of Physical and Emotional Symptoms in Chronic Hemodialysis Patients | |
| Drake et al. | Testing For Inflammatory Markers Associated With Most Diseases Treatable with Stem Cell Therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070228 |